Gene Therapy Immunogenicity will virtually unite leading decision-makers from large pharma and biotech to tackle the key immunogenicity roadblocks facing end-to-end drug development.
Bringing together the whos-who of gene therapy, this meeting allows you to virtually connect with industry leaders to collaboratively overcome the field’s challenges and find improved solutions. Immunogenicity is perhaps THE greatest challenge currently facing gene therapy drug developers and they need the expertise of solution providers to help drive their candidates through the clinic and beyond.
- Showcase your expertise to leading organizations by securing a virtual exhibition booth
- Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
- Maximize the balance of 2:1 live content and targeted online networking to generate leads and build new relationships with gene therapy pioneers
- Embrace the tech to meet your 2020 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively
Want to discuss further? Get in touch for more information.